1. Slieker, MG, Uiterwaal, CSPM, Sinaasappel, M, et al. (2005) Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands. Chest 128, 2309–2315.
2. O’Sullivan, BP & Freedman, SD (2009) Cystic fibrosis. Lancet 373, 1891–1904.
3. Turck, D, Braegger, CP, Colombo, C, et al. (2016) ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr 35, 557–577.
4. Black, PN & Scragg, R (2005) Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 128, 3792–3798.
5. Pojsupap, S, Iliriani, K, Sampaio, TZAL, et al. (2015) Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J Asthma 52, 382–390.
6. Janssens, W, Bouillon, R, Claes, B, et al. (2010) Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65, 215–220.
7. Ferrari, M, Schenk, K, Papadopoulou, C, et al. (2011) Serum 25-hydroxy vitamin D and exercise capacity in COPD. Thorax 66, 544–545.
8. McCauley, LA, Thomas, W, Laguna, TA, et al. (2014) Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis. Ann Am Thorac Soc 11, 198–204.
9. Sexauer, WP, Hadeh, A, Ohman-Strickland, PA, et al. (2015) Vitamin D deficiency is associated with pulmonary dysfunction in cystic fibrosis. J Cyst Fibros 14, 497–506.
10. Pincikova, T, Nilsson, K, Moen, IE, et al. (2011) Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr 65, 102–109.
11. Green, D, Carson, K, Leonard, A, et al. (2008) Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J Pediatr 153, 554–559.
12. Simoneau, T, Bazzaz, O, Sawicki, GS, et al. (2014) Vitamin D status in children with cystic fibrosis: associations with inflammation and bacterial colonization. Ann Am Thorac Soc 11, 205–210.
13. Stephenson, A, Brotherwood, M, Robert, R, et al. (2007) Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 85, 1307–1311.
14. Pincikova, T, Sandberg, JK & Hjelte, L (2017) Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial. Eur J Clin Nutr 71, 203–205.
15. Rovner, AJ, Stallings, VA, Schall, JI, et al. (2007) Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 86, 1694–1699.
16. Simoneau, T, Sawicki, GS, Milliren, CE, et al. (2015) A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients. J Cyst Fibros 15, 234–241.
17. Green, DM, Leonard, AR, Paranjape, SM, et al. (2010) Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. J Cyst Fibros 9, 143–149.
18. Boas, SR, Hageman, JR, Ho, LT, et al. (2009) Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. J Cyst Fibros 8, 270–272.
19. Shepherd, D, Belessis, Y, Katz, T, et al. (2013) Single high-dose oral vitamin D3 (stoss) therapy – a solution to vitamin D deficiency in children with cystic fibrosis? J Cyst Fibros 12, 177–182.
20. Sinaasappel, M, Stern, M, Littlewood, J, et al. (2002) Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 1, 51–75.
21. Moran, A, Pillay, K, Becker, DJ, et al. (2014) Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 15, 65–76.
22. Colombo, C, Russo, MC, Zazzeron, L, et al. (2006) Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 43, Suppl. 1, S49–S55.
23. Quanjer, PH, Stanojevic, S, Cole, TJ, et al. (2012) Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 40, 1324–1343.
24. Hillman, LS, Cassidy, JT, Popescu, MF, et al. (2008) Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol 43, 772–780.
25. Zittermann, A, Ernst, JB, Gummert, JF, et al. (2014) Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr 53, 367–374.
26. Lansing, AH, McDonald, C, Patel, RA, et al. (2015) Vitamin D deficiency in pediatric patients with cystic fibrosis: associated risk factors in the northern United States. South Med J 108, 164–169.
27. Norton, L, Page, S, Sheehan, M, et al. (2015) Prevalence of inadequate vitamin D status and associated factors in children with cystic fibrosis. Nutr Clin Pract 30, 111–116.
28. Chavasse, RJ, Francis, J, Balfour-Lynn, I, et al. (2004) Serum vitamin D levels in children with cystic fibrosis. Pediatr Pulmonol 38, 119–122.
29. Drincic, AT, Armas, LAG, Van Diest, EE, et al. (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20, 1444–1448.
30. Pannu, PK, Zhao, Y & Soares, MJ (2016) Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res 36, 201–213.
31. Weishaar, T & Rajan, S (2015) Importance of body weight and skin color in determining appropriate vitamin D3 supplement doses for children and adolescents. Pediatr Res 77, 370–375.
32. Vanstone, MB, Egan, ME, Zhang, JH, et al. (2015) Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 50, 441–446.
33. Herscovitch, K, Dauletbaev, N & Lands, LC (2014) Vitamin D as an anti-microbial and anti-inflammatory therapy for cystic fibrosis. Paediatr Respir Rev 15, 154–162.
34. Yim, S, Dhawan, P, Ragunath, C, et al. (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros 6, 403–410.
35. McNally, P, Coughlan, C, Bergsson, G, et al. (2011) Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J Cyst Fibros 10, 428–434.